Lp(a) ≥75 nmol/L has been associated with higher levels of non-culprit plaque rupture and non-culprit thin-cap fibroatheroma (TCFA) in patients with acute myocardial infarction (AMI).
Educational Partners and Supporters
(Founding Partner)
Novartis has provided with arm’s length sponsorship towards the set-up of the Lp(a) Forum. The content was developed independently by the Forum.